Goodwin provided advisory services to investor Gilde Healthcare on the financing of the acquisition of medical technology manufacturer Koscher & Würtz (K&W). While the financial details of the transaction were not disclosed, the acquisition follows Gilde Healthcare’s previous purchase of Chr. Diener in 2022. This move marks a significant step for Gilde Healthcare as it aspires to create a group of leading contract manufacturers of surgical instruments.
Koscher & Würtz, a precision surgical hand instrument manufacturer, will operate as a group company alongside Chr. Diener, employing approximately 300 highly qualified individuals. By combining forces, K&W and Chr. Diener aim to offer a broader product portfolio and leverage the exchange of knowledge and best practices. Their shared vision is to establish a leading contract manufacturer of precision medical instruments.
Founded in 1983, Koscher & Würtz has become a prominent player in its market niche, focusing on the development and manufacturing of reusable and disposable surgical instruments. The company’s commitment to quality and customer satisfaction has fostered long-term customer relationships and enabled growth alongside its customers.
Gilde Healthcare, an investor specializing in the healthcare sector, manages over €2.6 billion across two fund strategies: Venture & Growth and Private Equity. The Venture & Growth fund targets fast-growing digital health, medtech, and therapeutics companies in Europe and North America, while the private equity fund invests in profitable mid-market healthcare companies in Northwest Europe.
The Goodwin team, led by partner Winfried M. Carli and associate Daniel Wagner (both Private Equity/Finance, Munich), included partner Oded Schein (Tax, Munich), associate Philipp Lauer (Tax, Munich), and transaction lawyer Rina Omura (Private Equity/Finance, Munich). The transaction underscores Gilde Healthcare’s strategic growth in the healthcare sector and the collaborative efforts of its portfolio companies to enhance their capabilities in the surgical instruments market.
Read More: https://eurohealthleaders.com/
